company

FIZ PHARMA AS

6300 Ã…NDALSNES

Return on Equity
48,7 %
Current Ratio
1,86
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue13 966 000
Net Income1 034 000
Total Assets4 396 000
Total Equity2 123 000
Income (NOK)2022
Revenue13 966 000
Expenditure12 633 000
Operating Profit1 332 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Earnings Before Tax1 332 000
Tax298 000
Net Income1 034 000
Balance (NOK)2022
Total Fixed Assets160 000
Total Current Assets4 236 000
Total Assets4 396 000
Total Retained Equity2 093 000
Total Equity2 123 000
Total Long-Term Debt0
Total Current Debt2 274 000
Total Equity and Debt4 396 000
Cash flow (NOK)2022
Sales Income13 966 000
Other Income0
Revenue13 966 000
Cost of Goods Sold9 751 000
Salary Costs1 929 000
Depreciation40 000
Impairment0
Expenditure12 633 000
Operating Profit1 332 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Dividends400 000
Net Income1 034 000
Balance details (NOK)2022
Goodwill160 000
Total Intangible Assets160 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets160 000
Stock1 328 000
Total Investments0
Cash, Bank2 409 000
Total Current Assets4 236 000
Total Assets4 396 000
Total Equity2 123 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 442 000
Unpaid Taxes297 000
Dividends400 000
Other Current Debt237 000
Total Current Debt2 274 000
Total Equity and Debt4 396 000
Financial indicators2022
Return on Equity48,7 %
Debt-to-Equity Ratio0
Operating Profit Margin9,54 %
Current Ratio1,86
Quick Ratio4,48
Equity Ratio0,48
Gross Profit Margin30,18 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English